Article
Genetic risk assessment of lethal prostate cancer using polygenic risk score and hereditary cancer susceptibility genes.
Journal of translational medicine - 6 Jul 2023
Ruan Xiaohao, Huang Da, Huang Jingyi, Tsu James Hok-Leung, Na Rong
Abstract excerpt
BACKGROUND: The genetic risk of aggressive prostate cancer (PCa) is hard to be assessed due to the lack of aggressiveness-related single-nucleotide polymorphisms (SNPs). Prostate volume (PV) is a potential well-established risk factor for aggressive PCa, we hypothesize that polygenic risk score (PRS) based on benign prostate hyperplasia (BPH) or PV-related SNPs may also predict the risk of aggressive PCa or PCa...
Topics
Join the communities discussing this publication.
